INS and diabetes mellitus: To study the interconnection between these amyloidogenic diseases, animal models have been generated that co-express both human Aβ and IAPP pathologies, able to closely resemble the clinical presentation of diabetes, permitting a more precise replication of insulin-signaling defects that appears in humans.